To highlight the beginning of pancreatic cancer awareness month, we have saved the best - an inspiring discussion with Dr. Charles J. Yeo who is a master surgeon, clinician-scientist, mentor, and an inspiration to us all in the community from patients to researchers to clinicians. You don’t want to miss this episode!
Join us for a lively conversation with Bruce Platt (a Philly and Purple warrior legend), who is working hard in the trenches to improve the lives of people and families affected by this disease.
Chris Joseph as a survivor, living with pancreatic cancer, talks about his journey- the good, the tough and the spiritual bumps on his road to a healthy lifestyle and approach to tackling this disease. He has inspiring words for all!
You don't want to miss this conversation with the ultimate Purple Warriors, Dr. Lynn Matrisian(CSO) and President and CEO Julie Fleshman of the Pancreatic Cancer Action Network, and discussed everything from our collective concerns about clinical trial accrual to some exciting things happening in the field right now...
After taking a brief break, Winter and Brody return with a stimulating discussion with Dr. Peter Allen (Duke University). Topics include where have we come with patient outcomes over the past few decades; training surgeons; and can we identify high risk individuals early...
We have a stimulating conversation about evolution, science, innovation and pancreatic cancer with a true maverick in the field, Dr. Christine Iacobuzio-Donahue.
The guys talk about the state of the union of early detection strategies and some new opportunities from weight loss to depression.
Drs. Winter and Brody discuss the state of the union of precision medicine with a leader in the field (Dr. Mike Pishvaian).
Disclosures: Brody is on the SAB (Perthera) and Pishvaian was the CMO (no longer paid) of Perthera, and advised for Astrazeneca.
Drs. Winter and Brody have a conversation with a pioneer in the field about the history and future of pancreatic cancer research.
Drs. Winter and Brody discuss that this COVID-related drug (Remdesivir) has gotten a lot of media attention.
"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial" www.thelancet.com Published online April 29, 2020 https://doi.org/10.1016/S0140-6736(20)31022-9
Please tell us why you think understanding and treating pancreatic cancer is so challenging!
Have any connection and interest in understanding not only pancreatic cancer, but to cancer in general? Listen to a surgeon scientist and a Ph.D. scientist, both in the middle of their careers and leaders at their respective institutions, who have combined 50+ years of experience in the field--discuss with thought leaders in oncology the politics, the landscape, the science, the clinical trials, the challenges, and the opportunities within the field of cancer research.
